168 related articles for article (PubMed ID: 37738835)
1. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
Coffey K; Dixon LB; Sevilimedu V; Jochelson MS; Sung JS
Eur J Radiol; 2023 Nov; 168():111097. PubMed ID: 37738835
[TBL] [Abstract][Full Text] [Related]
2. Utility of Targeted Ultrasound to Predict Malignancy Among Lesions Detected on Contrast-Enhanced Digital Mammography.
Coffey K; Sung J; Comstock C; Askin G; Jochelson MS; Morris EA; D'Alessio D
AJR Am J Roentgenol; 2021 Sep; 217(3):595-604. PubMed ID: 33025811
[No Abstract] [Full Text] [Related]
3. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
Nida BA; Rooney TB; Miller MM
AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
[No Abstract] [Full Text] [Related]
4. Enhancement Type at Contrast-enhanced Mammography and Association with Malignancy.
Kim G; Mehta TS; Brook A; Du LH; Legare K; Phillips J
Radiology; 2022 Nov; 305(2):299-306. PubMed ID: 35819328
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
6. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
[TBL] [Abstract][Full Text] [Related]
7. MRI only detected lesions: Can contrast enhanced mammography guided biopsy be an alternative method: Initial clinical findings.
Aribal E; Guldogan N; Seker ME; Yilmaz E; Turk EB
Eur J Radiol; 2024 Apr; 173():111373. PubMed ID: 38364588
[TBL] [Abstract][Full Text] [Related]
8. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
[No Abstract] [Full Text] [Related]
9. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
12. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
[TBL] [Abstract][Full Text] [Related]
13. Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
Long R; Cao K; Cao M; Li XT; Gao F; Zhang FD; Yu YZ; Sun YS
Clin Breast Cancer; 2021 Jun; 21(3):256-262.e2. PubMed ID: 33243676
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Contrast-Enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions.
Klarić K; Šribar A; Budisavljević A; Labinac L; Valković Zujić P
Diagnostics (Basel); 2023 Jun; 13(11):. PubMed ID: 37296810
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.
Cozzi A; Schiaffino S; Fanizza M; Magni V; Menicagli L; Monaco CG; Benedek A; Spinelli D; Di Leo G; Di Giulio G; Sardanelli F
Eur Radiol; 2022 Nov; 32(11):7388-7399. PubMed ID: 35648209
[TBL] [Abstract][Full Text] [Related]
16. Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography.
Amir T; Hogan MP; Jacobs S; Sevilimedu V; Sung J; Jochelson MS
AJR Am J Roentgenol; 2022 May; 218(5):797-808. PubMed ID: 34817195
[No Abstract] [Full Text] [Related]
17. Contrast-Enhanced Mammography for Newly Diagnosed Breast Cancer in Women With Breast Augmentation: Preliminary Findings.
Carnahan MB; Pockaj B; Pizzitola V; Giurescu ME; Lorans R; Eversman W; Sharpe RE; Cronin P; Patel BK
AJR Am J Roentgenol; 2021 Oct; 217(4):855-856. PubMed ID: 33728971
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
Narayan AK; Visvanathan K; Harvey SC
Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and precision of contrast enhanced mammography versus MRI for predicting breast cancer size: how "good" are they really?
Taylor DB; Burrows S; Dessauvagie BF; Saunders CM; Ives A
Br J Radiol; 2023 Mar; 96(1144):20211172. PubMed ID: 36753450
[TBL] [Abstract][Full Text] [Related]
20. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
